Summary
61 / 100 · Bulios Score
What speaks for it
- It could repay all its net debt from 1.3 years of operating profit.
- It passes 8 of the 9 points of the Piotroski financial health test.
What to watch
- The share price is above the Bulios Fair Price.
- Out of every 100 JPY of revenue, only 3.1 JPY is left as net profit.
- It earns only 3.4 JPY a year on every 100 JPY of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 10.3 JPY for 1 JPY of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (JPY)
Diluted EPS (JPY)
- Analyst estimate
Revenue grew by 9.3% a year over 5 years. Over the last 3 years it grew by 7.1% a year. For the next fiscal year analysts expect revenue to grow by 2.3%. Earnings per share grew by 4.0% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 JPY of revenue goes
- Cost of sales 65 JPY
- Research and development 2.9 JPY
- Sales and administration 28 JPY
- Taxes and other 0.3 JPY
- Net profit 3.1 JPY
Net profit, industry median (Business Equipment & Supplies) 4.8 JPY
Out of every 100 JPY of revenue, 3.1 JPY is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 3.6 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 2.93%
- Paid out of profit
- 30%
- Raised in a row
- 4 years
You receive $0.28 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.